John McAfee

9PUBLICATIONS
12CO-AUTHORS
Predictive and prognostic markersChemical engineering designCancer diagnosisMedical infection agents (incl. prions)Evolutionary impacts of climate change
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (9)

|Sep 04, 2026
Punctate nuclear low-risk HPV chromogenic in situ hybridization in digital papillary adenocarcinoma: a practical tool for identifying HPV42 in routine pathology practice.

|Apr 02, 2026
Spitz Melanocytoma With a Novel CPEB2::MAP3K2 Rearrangement: A Case Report.

John L McAfee, Claudia M Ricotti, Shira Ronen

|Jul 10, 2025
Cytokeratin and Neuroendocrine Positivity in Cutaneous Small Blue Round Cell Tumor-Is It Always Merkel Cell Carcinoma?

Simon Moubarak, John McAfee, Karen Fritchie

|Feb 19, 2024
Are there specific cytologic features that can predict BRAFV600E mutational status of papillary thyroid carcinoma in fine-needle aspiration specimens?

Juliann M Mendes, Tarik M Elsheikh, Jessica Di Marco

|Oct 19, 2022
Combined utility of p16 and BRAF V600E in the evaluation of spitzoid tumors: Superiority to PRAME and correlation with FISH.

John L McAfee, Richard Scarborough, Xuefei Sophia Jia

|Sep 03, 2021
Preferentially expressed antigen in melanoma and p16 expression in acral melanocytic neoplasms.

Jeffrey D McBride, John L McAfee, Melissa Piliang

Pageof 2

Frequent Collaborators

6 joint publications

Jennifer S Ko

5 joint publications

Steven D Billings

2 joint publications

Perry E Bickel

2 joint publications

Shira Ronen